LLY

966.35

+1.98%↑

JNJ

221.39

+0.12%↑

ABBV

202.82

+0.84%↑

UNH

384.32

+1.29%↑

AZN

181.82

-0.27%↓

LLY

966.35

+1.98%↑

JNJ

221.39

+0.12%↑

ABBV

202.82

+0.84%↑

UNH

384.32

+1.29%↑

AZN

181.82

-0.27%↓

LLY

966.35

+1.98%↑

JNJ

221.39

+0.12%↑

ABBV

202.82

+0.84%↑

UNH

384.32

+1.29%↑

AZN

181.82

-0.27%↓

LLY

966.35

+1.98%↑

JNJ

221.39

+0.12%↑

ABBV

202.82

+0.84%↑

UNH

384.32

+1.29%↑

AZN

181.82

-0.27%↓

LLY

966.35

+1.98%↑

JNJ

221.39

+0.12%↑

ABBV

202.82

+0.84%↑

UNH

384.32

+1.29%↑

AZN

181.82

-0.27%↓

Home・Lista de Ações・Medtronic PLC
Search

Medtronic PLC

Fechado

SetorSaúde

74.54 -1.95

Comprar

Atualização de preço 11 de mai. de 2026, 19:59 UTC

ComprarVender

Visão Geral

Variação de preço das ações

24h

Atual

Mín

74.4

Máximo

76.08

Indicadores-chave

By Trading Economics

Rendimento

-231M

1.1B

Vendas

57M

9B

P/E

Médio do Setor

22.308

49.8

EPS

1.36

Rendimento de Dividendos

3.54

Margem de lucro

12.675

Funcionários

95,000

EBITDA

124M

2.5B

Recomendações

By TipRanks

Recomendações

Comprar

Previsão para 12 meses

+38.65% upside

Dividendos

By Dow Jones

Rendimento de Dividendos

Médio do Setor

3.54%

2.25%

Próximos Ganhos

3 de jun. de 2026

Próxima data de dividendos

10 de jul. de 2026

Próxima data de ex-dividendo

26 de jun. de 2026

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

-27B

101B

Abertura anterior

76.49

Fecho anterior

74.54

Sentimento de Notícias

By Acuity

50%

50%

153 / 347 Ranking em Healthcare

Pontuação Técnica

By Trading Central

Confiança

Weak Bearish Evidence

83.26 / 84.875 Suporte e Resistência

Medtronic PLC Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

10 de mar. de 2026, 11:19 UTC

Aquisições, Fusões, Aquisições de Empresas

Medtronic to Buy Scientia Vascular in $550 Million Deal

DJ

Ler

17 de fev. de 2026, 12:43 UTC

Ganhos

Medtronic 3Q Profit Falls Despite Higher Revenue

DJ

Ler

3 de fev. de 2026, 13:53 UTC

Aquisições, Fusões, Aquisições de Empresas

Medtronic to Acquire CathWorks in Deal Valued Up to $585 Million

DJ

Ler

22 de abr. de 2026, 11:27 UTC

Ganhos

Intuitive Surgical Earnings Show Big Beats Don't Always Spark Stock Rallies -- Barrons.com

DJ

Ler

20 de abr. de 2026, 11:50 UTC

Aquisições, Fusões, Aquisições de Empresas

Medtronic Completes Acquisition Of CathWorks, Expanding Its Leadership In Transforming Care For Patients With Cardiovascular Disease >MDT

DJ

Ler

24 de mar. de 2026, 20:59 UTC

Ganhos

Medtronic PLC Cuts FY26 View To Adj EPS $5.50-Adj EPS $5.54 >MDT

DJ

Ler

10 de mar. de 2026, 10:46 UTC

Aquisições, Fusões, Aquisições de Empresas

Medtronic: Scientia Deal Complements Neurovascular Portfolio >MDT

DJ

Ler

10 de mar. de 2026, 10:46 UTC

Aquisições, Fusões, Aquisições de Empresas

Medtronic: Scientia Deal Includes Potential Undisclosed Earn-Out, Milestone Payments >MDT

DJ

Ler

10 de mar. de 2026, 10:45 UTC

Aquisições, Fusões, Aquisições de Empresas

Medtronic: Scientia Vascular Acquisition Valued at $550 Million >MDT

DJ

Ler

10 de mar. de 2026, 10:45 UTC

Aquisições, Fusões, Aquisições de Empresas

Medtronic to Acquire Scientia Vascular >MDT

DJ

Ler

17 de fev. de 2026, 21:21 UTC

Ganhos

These Stocks Are Today's Movers: Paramount, Masimo, Medtronic, Kyndryl, eToro, Genuine Parts, Southwest, and More -- Barrons.com

DJ

Ler

17 de fev. de 2026, 18:11 UTC

Ganhos

Medtronic Posts Better-Than-Expected Earnings. Here's Why the Stock Is Falling. -- Barrons.com

DJ

Ler

17 de fev. de 2026, 14:48 UTC

Ganhos

Medtronic Posts Better-Than-Expected Earnings. Here's Why the Stock Is Falling. -- Barrons.com

DJ

Ler

17 de fev. de 2026, 13:00 UTC

Ganhos

Medtronic Posts Better-Than-Expected Earnings. Here's Why the Stock Is Falling. -- Barrons.com

DJ

Ler

17 de fev. de 2026, 12:05 UTC

Ganhos

Medtronic Posts Better-Than-Expected Earnings. Here's Why the Stock Is Falling. -- Barrons.com

DJ

Ler

17 de fev. de 2026, 11:47 UTC

Ganhos

Medtronic Sees 2026 EPS up 4.5%, Excluding Potential Impact From Tariffs >MDT

DJ

Ler

17 de fev. de 2026, 11:47 UTC

Ganhos

Medtronic Still Sees FY26 Organic Revenue Up About 5.5% >MDT

DJ

Ler

17 de fev. de 2026, 11:46 UTC

Ganhos

Medtronic FY26 View Includes Potential Impact From Tariffs of About $185M >MDT

DJ

Ler

17 de fev. de 2026, 11:46 UTC

Ganhos

Medtronic Backs FY26 View of Adj EPS $5.62-Adj EPS $5.66 >MDT

DJ

Ler

17 de fev. de 2026, 11:46 UTC

Ganhos

Medtronic Reiterates FY26 Organic Rev Growth, EPS Guidance >MDT

DJ

Ler

17 de fev. de 2026, 11:45 UTC

Ganhos

Medtronic 3Q Adj EPS $1.36 >MDT

DJ

Ler

17 de fev. de 2026, 11:45 UTC

Ganhos

Medtronic 3Q Neuroscience Portfolio Rev $2.56B >MDT

DJ

Ler

17 de fev. de 2026, 11:45 UTC

Ganhos

Medtronic 3Q Organic Revenue Up 6.0% >MDT

DJ

Ler

17 de fev. de 2026, 11:45 UTC

Ganhos

Medtronic 3Q Sales $9.02B >MDT

DJ

Ler

17 de fev. de 2026, 11:45 UTC

Ganhos

Medtronic 3Q Diabetes Rev $796M >MDT

DJ

Ler

17 de fev. de 2026, 11:45 UTC

Ganhos

Medtronic 3Q Cardiovascular Portfolio Rev $3.46B >MDT

DJ

Ler

17 de fev. de 2026, 11:45 UTC

Ganhos

Medtronic 3Q Medical Surgical Portfolio Rev $2.17B >MDT

DJ

Ler

17 de fev. de 2026, 11:45 UTC

Ganhos

Medtronic 3Q Net $1.14B >MDT

DJ

Ler

17 de fev. de 2026, 11:45 UTC

Ganhos

Medtronic 3Q EPS 89c >MDT

DJ

Ler

17 de fev. de 2026, 09:53 UTC

Ações em Alta

Stocks to Watch Tuesday: Norwegian, Hyatt, Zim, Medtronic -- WSJ

DJ

Ler

Comparação entre Pares

Variação de preço

Medtronic PLC Previsão

Preço-alvo

By TipRanks

38.65% parte superior

Previsão para 12 meses

Média 105.58 USD  38.65%

Máximo 120 USD

Mínimo 86 USD

Com base em 21 analistas de Wall Street que oferecem metas de preço de 12 meses para Medtronic PLC - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Comprar

21 ratings

12

Comprar

9

Manter

0

Vender

Com base em 21 analistas que deram avaliações de ações para Medtronic PLC - Dist nos últimos 3 meses.

Pontuação Técnica

By Trading Central

83.26 / 84.875Suporte e Resistência

Curto Prazo

Weak Bearish Evidence

Recent bearish events outweigh bullish events.

Médio Prazo

Bullish Evidence

All events are bullish.

Longo Prazo

Bearish Evidence

All events are bearish.

Sentimento

By Acuity

153 / 347 Ranking em Saúde

Sentimento de Notícias

Neutral

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Abaixo da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Medtronic PLC

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and other products. The Neuroscience Portfolio segment offers medical devices and implants, biologic solutions, spinal cord stimulation and brain modulation systems, implantable drug infusion systems, and interventional products, as well as nerve ablation system under the Accurian name. The segment offers its products for spinal surgeons, neurosurgeons, neurologists, pain management specialists, anesthesiologists, orthopedic surgeons, urologists, urogynecologists, and interventional radiologists, as well as ear, nose, and throat specialists; and energy surgical instruments. The Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure and electrosurgery products, AI-powered surgical video and analytics platform, robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology products, gastrointestinal and hepatologic diagnostics and therapies, and therapies to treat other non-exclusive diseases and conditions; and patient monitoring and airway management products. The Diabetes Operating Unit segment provides insulin pumps and consumables, continuous glucose monitoring systems, and InPen, a smart insulin pen system. The company was founded in 1949 and is headquartered in Galway, Ireland.

Outras ações do setor

LLY

Eli Lilly and Co.

966.35

↑ +1.98%

JNJ

Johnson and Johnson

221.39

↑ +0.12%

ABBV

AbbVie Inc

202.82

↑ +0.84%

UNH

UnitedHealth Group Inc

384.32

↑ +1.29%

AZN

AstraZeneca PLC

181.82

↓-0.27%
help-icon Live chat